Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
The Century of Biology is an English-language biotech newsletter run by Elliot Hershberg on Substack, positioned as “data, companies, and ideas from the frontier of biology.” Its core thesis is that if the 20th century belonged to physics, the 21st century will belong to biology. The site covers DNA sequencing, gene editing, CRISPR, AI modeling of living systems, and digital biology startups, combining scientific explanation with industry analysis.
It is not a traditional news site, but rather an in-depth newsletter. Readers can subscribe by email through Substack, read archived articles, and follow the author’s ongoing research and views on frontier biotech companies. The author has a background in biology and computer science, holds a PhD in genetics from Stanford, and has worked on translational development for cancer vaccines, open-source genomics software, and the Bio fund at the early-stage Bay Area venture firm Amplify. As a result, the content leans more toward professional analysis than general science popularization.
The captured page only shows “Subscribe” and does not disclose any clear paid tiers or prices. Common Substack newsletter models include free subscriptions, paid subscriptions, or a hybrid model, but based on the current text alone, it is not possible to confirm whether it charges, how much it costs, or which content is protected by a paywall.
The main strengths are its very clear positioning and focus on high-value topics such as the intersection of AI and biology, genomics platforms, and life sciences entrepreneurship. The author’s background adds credibility, and more than 27,000 subscribers also indicate that it already has a stable level of influence. The downsides are that the content is in English and relatively dense professionally, making it less friendly to readers without a biology or investment background. In addition, the captured information lacks key operational details such as update frequency and paid subscriber benefits.
Best suited for biotech founders, life sciences researchers, VCs and industry investors, AI for Science practitioners, and readers who want to understand trends in next-generation biotechnology platforms. It is less suitable for users who only want basic biology explainers or Chinese-language information.
The site is built on Substack. Access to Substack in mainland China may fluctuate depending on the network environment: it may open in some regions, while loading, subscribing, or email confirmation may be unstable in others. Therefore, it is rated as “partially restricted.” For long-term reading, it is recommended to also use email subscriptions or RSS/forwarding tools as a backup.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on centuryofbio.com official site.
centuryofbio.com is an United States News provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach centuryofbio.com directly.